Background/Aims: Macrophages, the most plastic cells in the haematopoietic system, are found in all tissues and show great functional heterogeneity. Sphingosine 1-phosphate (S1P)/ S1P receptors (S1PRs) system is widely involved in the process of inflammatory disease, whereas little evidence concerning its role in functional macrophage polarization is available. Thus, the present study was designed to evaluate the effects of S1P/S1PRs on functional polarization of macrophage in mouse bone marrow (BM)-derived monocyte/macrophages (BMMs). Methods: For the detection of M1 macrophage markers, such as CD86, tumor necrosis factor (TNF)-a, monocyte chemotactic protein (MCP)-1/ chemokine (C-C motif) ligand (CCL) 2, nitric oxide synthase (NOS) 2, and macrophage inflammatory protein (MIP)-1b, RT-qPCR and cytometric bead array (CBA) were performed in cultured primary BMMs after the treatment with selective S1PR 2/3 antagonists or specific S1PRs siRNA. Western blotting and immunofluorescence were used for the detection of phosphorylation of JNK1/2. Results: BMMs expressed S1PR 1-3 and interestingly, S1PR 2/3 , but not S1PR 1 , mediates S1P-induced M1 macrophage polarization of BMMs as their siRNA or antagonists reduced M1 genes' expression. We found that PTX (inhibitor of G(a) i/o ), LY294002 (inhibitor of PI3K) or SP600125 (inhibitor of JNK1/2) prevented up-regulation of M1 genes expression mediated by S1P/S1PR 2/3 signal, and S1P-induced JNK phosphorylation was inhibited by antagonists of S1PR 2/3 , PTX or LY294002. Conclusion: Collectively, our results demonstrate that S1P/S1PR 2/3 plays a key role in regulating M1 type polarization of BMMs and acts by activating G(a) i/o /PI3K/JNK signaling pathway, with potential implications for new approaches to inflammatory liver disease therapy.
Introduction
Macrophages, the most plastic cells in the haematopoietic system, are found in all tissues and show great functional heterogeneity [1] . They display an important role in innate and adaptive immune response. Functionally, macrophages can be classified in classically activated M1 macrophages and alternatively activated M2 macrophages [2, 3] . M1 macrophages express specific marker CD86 [4] as well as produce pro-inflammatory cytokines and chemokines such as tumor necrosis factor (TNF)-a, monocyte chemotactic protein (MCP)-1/ chemokine (C-C motif) ligand (CCL) 2 , interleukin (IL)-1, IL-6, nitric oxide synthase (NOS) 2, macrophage inflammatory protein (MIP)-1β [5, 6] . In contrast, M2 macrophages produce anti-inflammatory cytokine Arginase-1 and express special receptor CD163 and CD206 and play a crucial role in healing and tissue repair [7, 8] . It has been reported that macrophage polarization and function is largely controlled by chemokines, cytokines, and different varieties of ligands of G-protein-coupled receptor (GPCR) like lipopolysaccharide (LPS) [9] [10] [11] .
Sphingosine 1-phosphate (S1P), one of the most important pleiotropic lysophospholipid mediators, is converted primarily from sphingosine by sphingosine kinase (SphK) and plays key roles in regulating the polarization of immune cells and secretion of inflammatory mediators [12, 13] . Recently, increasing evidence demonstrate that S1P is involved in the progression of various inflammatory-related diseases such as inflammatory bowel disease [14] , inflammatory skin diseases [15] and rheumatoid arthritis [16] . Of note, S1P exerts different cellular functions via its receptors or as a cell second messenger [17] . Until now, studies have shown that most S1P biological functions were mediated by its receptors [18] . S1P receptors (S1PRs) are classified into 5 types, named S1PR [1] [2] [3] [4] [5] , while S1PR 1-3 is widely expressed. These S1PRs bind to distinct heterotrimeric G-proteins and regulate different signaling pathways [19] . Our previous studies have shown that S1P/S1PR 2/3 is involved in bile duct ligation (BDL)-or carbon tetrachloride (CCl 4 )-induced liver injury [20] . However, the role of S1P/S1PRs in functional polarization of macrophage remains incompletely defined.
Accumulating evidence showed that, among the complex array of the GPCR-activated intracellular signaling pathways, c-Jun N-terminal kinase (JNK), p38, extracellular regulated protein kinases (ERK), phosphatidylinositol 3-kinase (PI3K) and Rac1 are involved in macrophage polarization, thus contributing to inflammation [21] . For example, JNK activation is required for M1 macrophage polarization during obesity-induced liver inflammation, and JNK knock down mice abrogates M1-related inflammation and fibrosis [22] . Additionally, activation of p38 and JNK signaling induces increase of M1 genes expression upon Toll-like receptor (TLR) 4-induced inflammation [23, 24] . Moreover, M1 macrophage polarization can be induced by Forkhead box protein O1 (Fox O1) phosphorylation depended on PI3K and ERK signaling [25] . Another central regulator in cell polarization is Rac1, one of the important members of GTPase family, which is also involved in cell polarization for their switch role (GTP-bound for active) [26] .
Our previous study revealed that hepatic S1P levels were significantly up-regulated at the early stage, and remained at a high level during with the progression of liver injury in human and mouse liver injury caused by multiple etiologies [27, 28] . Meanwhile, the analysis in vivo and in vitro suggested that bone marrow (BM)-derived monocytes/macrophages (BMMs) were recruited to the damaged liver [29, 30] and exposed to high levels of S1P in the hepatic microenvironment. Furthermore, it was also found that BMMs presented a proinflammatory property during the process [20] . Based on these previous in vivo and in vitro studies, we determined whether S1P is involved in the pro-inflammatory M1 polarization of BMMs, and identified the signaling pathway that mediates S1P-induced M1 polarization in BMMs. In the present study, we found that primary murine BMMs express S1PR 1 , S1PR 2 and S1PR 3 and S1P can promote BMM polarization toward M1 phenotype through S1PR 2 and S1PR 3 . S1PR 2/3 mediated S1P-induced M1 polarization via G(a) i/o /PI3K/JNK pathway in
Isolation and cultivation of mouse primary BMMs
BMMs are primary macrophage cells, derived from BM cells in vitro in the presence of growth factors. Macrophage colony-stimulating factor (M-CSF) is secreted by L929 cells and is used in the form of L929-conditioned medium. Firstly, L929 cells were obtained from the Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, and were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) in 5% CO 2 at 37˚C for 7 days (replacing culture medium at day 4). L929 cells were harvested using trypsin, and then implanted with 4.7×10 5 / bottle (BD Falcon) and cultured in the presence of DMEM-Gluta MAX medium. After 7 days, the medium was sterilized by filtrating through a 0.22 μm filter and used as L929-conditioned medium.
Next, ICR mice at 4 weeks of age were sacrificed by cervical dislocation at the time of BM harvest. BM cells were extracted from the tibias and femurs by flushing with culture medium using a 25-gauge needle. The cells were then passed through a 70-mm nylon mesh (BD Biosciences, Franklin Lakes, NJ) and were washed three times with PBS containing 2% FBS. Extracted BM cells were implanted with 2.4×10 7 / 100 mm culture dish (BD Falcon) and cultured for 7 days in the presence of L929-conditioned medium (replacing culture medium at day 3 and 5). After 7 days, Cells were serum starved for 12 hours prior to treatment with W146 (1 μmol/L), JTE-013 (10 μmol/L), CAY-10444 (10 μmol/L), PTX (10 ng/mL), U0126 (10 μmol/L), SB203580 (10 μmol/L), SP600125 (50 μmol/L), LY294002 (10 μmol/L) or NSC23766 (100 μmol/L) for additional 1 hour. Pretreated mouse primary BMMs were then allowed to S1P (1 μmol/L) administration for another 6 hours.
Mouse models of liver injury
Adult ICR mice received intraperitoneal injections of 1 μL/g body weight of a CCl 4 /olive oil (OO) mixture, 1:9 v/v, twice per week. SKI (0.4 mg/kg B.W.) was administered intraperitoneally one day before CCl 4 or OO treatment and twice per week for 4 weeks (n=6 per group). The mice were sacrificed at 4 weeks of CCl 4 treatment, always on the day after the last injection. All animal work was conformed to the Ethics Committee of Capital Medical University and in accordance with the approved guidelines (specific institutional approval number of animal experiment: AEEI-2014-131).
Cell migration assay
Serum-starved BMMs were treated with vehicle, LPS or IL-4 six hours, respectively. These cells were then seeded to the upper chamber, and allowed to migration for another 4 hours in the presence of 1 μmol/L S1P. The chambers were incubated at 37 °C in 5% CO 2 . Cells migrated to the lower surface of the filter were hematoxylin stained and quantified by cell counting. The migration index was defined as the number of cells in the lower chamber under the tested condition divided by the number of cells under control. 
RT-qPCR
Total RNA was extracted from cells or liver frozen specimen using RNeasy mini kit (Qiagen, Hilden, Germany) and the quantity and purity of RNA was determined by NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific). cDNA was synthesized using oligo (dT) and M-MLV reverse transcriptase (Invitrogen). RT-qPCR was performed using TaqMan® Universal PCR Master Mix or SYBR Green qPCR Master Mix on the ABI 7300 TH Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). All RT-qPCR assays and independent experiments were performed in triplicate respectively. Relative mRNA expression normalized to the house-keeping gene 18S rRNA was carried out using 2 -ΔΔCt method. All primers were synthesized by Biotech (Beijing, China). Primers used for RT-qPCR were as follows:
Mouse 18S Immunofluorescence staining BMMs (5, 000) were plated in the well of 96-well plates (Corning, NY) and treated with chemicals after overnight attachment. The cells were fixed with 4% paraformaldehyde in PBS for 30 min and permeabilized with 0.5% Triton X-100 in PBS (Amresco, OH) for 15 min. After blocked with 2% BSA (Roche, Switzerland), they were incubated with anti-S1PR 1 , anti-S1PR 2 or anti-S1PR 3 rabbit polyclonal antibody (1:100, Santa Cruz Biotechnology, CA), anti-phorspho-JNK1/2 rabbit polyclonal antibodies (1:100, Cell Signaling Technology, Beverly, MA), Respectively, FITC-conjugate affinipure goat-anti-rabbit IgG (1:100, Jackson Immunoresearch, PA) was used as secondary antibodies. At last, nuclei were incubated with 10 μg/mL DAPI for 5 min.
Western blot analysis
Protein samples were separated on 12% SDS-PAGE, transferred onto a nitrocellulose membrane (Millipore, Massachusetts, USA) and blocked with 5% (w/v) bovine serum albumin (BSA) in TBS pH 7.4. Then, the membrane was incubated with rabbit anti-JNK1/2 (1:1, 000; Cell Signaling Technology, Beverly, MA), rabbit anti-phorspho-JNK1/2 (1:1, 000; Cell Signaling Technology, Beverly, MA) or rabbit anti-β-actin antibody (1:1, 000, Abcam, UK), followed by incubation with IRDyeTM 800-conjugated goat anti-rabbit IgG (1:10, 000, LI-COR Biosciences, Lincoln, NE) as secondary antibodies. Protein level was visualized by the LI-COR Odyssey® Imaging System and assessed by Odyssey® software (LI-COR Biosciences, Lincoln, NE), respectively. RNAi in vitro siRNA sequence targeting specifically mouse S1PR 1-3 was purchased (L-051684-00, L-063765-00, L-040959-00; Dharmacon, Lafayette, CO). Forty to fifty percent confluent BMMs were prepared. Transient transfection of siRNA (40 nmol/L) was used by employing Lipofectamine RNAi MAX (Invitrogen, Carlsbad, CA) as recommended by the manufacturer. Control cells were treated with RNAi negative control duplexes (scramble siRNA, 40 nmol/L). After 24 hours, cells were used to fulfill further experiments.
Measurement of cytokine and chemokine by CBA

Statistical analysis
The results are expressed as mean ± SEM. Statistical significance was assessed by Student's t-test or one-way analysis of variance (ANOVA) for analysis of variance when appropriate. P < 0.05 was considered to be significant. All results were verified in at least three independent experiments.
Results
S1P promotes M1 macrophage polarization in BMMs
To assess the efficiency and capacity of the BMM polarization in vitro, we treated primary mouse BMMs with LPS, a potent inducer of M1 macrophage polarization [31] . RT-qPCR analysis showed that inflammatory cytokine expressions including TNF-α, MCP-1/CCL2, NOS2, MIP-1β and CD86 were significantly increased in BMMs upon LPS (10 ng/ mL) challenge (Fig. 1A) . In contrast, the mRNA expression of Arginase-1 was obviously upregulated in BMMs treated with IL-4 (5 ng/mL) (Fig. 1B) , indicating that LPS and IL-4 can be effectively used to trigger M1 BMMs and M2 BMMs, respectively.
We next employed the BMMs to determine the effect of S1P on macrophage polarization in vitro. The mRNA expression of M1 markers (TNF-a, MCP-1/CCL2, NOS2, MIP-1b and CD86) in BMMs in response to S1P at different time was determined. BMMs were treated with 1 μmol/L S1P and collected after 0, 2, 4, 6, 12, 18, and 24 hours. RT-qPCR analysis demonstrated that the mRNA expression of M1 markers including TNF-a, MCP-1/CCL2, NOS2, MIP-1b and CD86 were elevated at 4 hours then reached to the topmost level (~ 30.8-fold, ~ 27.6-fold, ~ 135.5-fold, ~ 25.4-fold, and ~ 4.4-fold, respectively) at 6 h ( Fig. 1C-G) . However, S1P had no effects on M2 marker Arginase-1 mRNA expression (Fig. 1H) . Moreover, the mRNA expression of CD163 and CD206 were also unchanged after treatment with S1P (Fig. 1I) . These results indicate that M1, but not M2 macrophage polarization was induced by S1P in BMMs.
Antagonism of S1PR 2/3 inhibits S1P-induced BMMs polarization toward M1 phenotype
To further assess whether S1P triggered BMM polarized toward M1 phenotype via its cell surface receptors, we performed the same experiment using H 2 S1P, a structural analog of S1P that is only able to exert its biological functions through a surface bound S1PRs. As shown in Fig. 2A , the effect of S1P on TNF-a mRNA expression was completely mimicked by H 2 S1P. These results indicate that S1P induces BMM polarized toward M1 type via its cell surface receptors. We next used immunofluorescence assays to determine the expression of S1PR 1 , S1PR 2 or S1PR 3 in BMMs. As expected, the immunostaining for these receptors were detected (Fig. 2B) . To further determine which receptors mediate the S1P-induced M1 macrophage polarization, we next employed pharmacological antagonist of S1PRs and detected the expression of M1 markers with RT-qPCR and CBA. As shown in Fig. 2C , treatment of BMMs with S1P lead to up-regulation of mRNA expression of M1 markers, including TNF-α and MCP-1/CCL2, and these increases were abrogated by specific S1PR 2 antagonist JTE-013 (10 μmol/L) or S1PR 3 antagonist CAY-10444 (10 μmol/L). However, the mRNA expression of TNF-a and MCP-1/CCL2 were unchanged after specific S1PR 1 antagonist W146 (1 μmol/L) pretreatment. Moreover, the protein level of these M1 markers (TNF-a, and MCP-1/CCL2) was significantly decreased by JTE-013 or CAY-10444 after S1P stimulation, as analyzed by CBA (Fig. 2D) .
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Cell Fig. 2 . S1P-induced M1 polarization is prevented by S1PR 2/3 antagonists in BMMs. (A) The mRNA expression of TNF-α in BMMs treated with S1P or H 2 S1P (0 to 1 μmol/L) for 6 hours. Stock solutions of S1P and H 2 S1P were dissolved in methanol at -80℃. Dilutions of S1P and H 2 S1P were freshly prepared after evaporation of methanol by resuspension in 0.4% fatty acid-free BSA and sonication. (B) Representative images of immunofluorescence staining for S1PR 1 , S1PR 2 and S1PR 3 (green) were shown in BMMs. 
Genetic ablation of S1PR 2/3 inhibits S1P-induced BMMs polarization toward M1 phenotype
To further evaluate the significant role of S1PRs, individual S1PRs was knocked down by specific siRNA. We first confirmed that genetic ablation of S1PR 1 , S1PR 2 or S1PR 3 effectively silenced the corresponding target gene at the mRNA level and their mRNA expression was reduced by 87%, 82%, and 86%, respectively in mouse BMMs (Fig. 3A) . S1PR 1 , S1PR 2 or S1PR 3 siRNA in vitro did not alter the expression of other S1PRs, which confirmed the specificity of these siRNAs (data not shown). Furthermore, silencing S1PR 2/3 prevented the mRNA and protein expression of TNF-a and MCP-1/CCL2 induced by S1P administration (Fig. 3B-D) . These results further confirm that S1PR 2/3 , but not S1PR 1 mediates the S1P-induced BMM polarized toward M1 phenotype in vitro.
G(α) i/o , PI3K and JNK signal mediates the effect of S1P on M1 polarization in BMMs
As a G protein-coupled receptor, the biological function of S1P/S1PRs depends on multiple signaling pathways, such as ERK, p38 and JNK signaling pathways [22, [32] [33] [34] [35] . Our previous study indicated that S1P activated PI3K and Rac1 to promote macrophage migration. To identify the responsible signal pathways for M1 polarization of BMMs regulated by S1P, pharmacological inhibitors of signal transduction, including U0126 (ERK inhibitor), SB203580 (p38 inhibitor), SP600125 (JNK1/2 inhibitor), LY294002 (PI3K inhibitor) and NSC23766 (Rac1 inhibitor) were applied. The S1P-induced increase of TNF-a, and MCP-1/ CCL2 protein level were only lessened by LY294002 and SP600125 in mouse primary BMMs (Fig. 4 A-B) whereas U0126, SB203580, and NSC23766 had no effect on S1P-induced M1 markers expression (Fig. 4 A-B) , indicating that PI3K and JNK signal, but not ERK, p38, Rac1 signal, might be necessary for S1P-induced M1 polarization of BMMs. Moreover, PTX (G(a) i/o protein inhibitor) pre-treatment also inhibited S1P-induced M1 markers (TNF-a and MCP-1/CCL2) mRNA expression (Fig. 4 A-B) . Furthermore, PTX, LY294002 and SP600125 pretreatment also decreased the up-regulation of protein levels of TNF-a and MCP-1/CCL2 in BMMs treated with S1P, as detected by CBA (Fig. 5 A-C) . These results indicate that G(a) i/o , PI3K and JNK signals involves in S1P-induced BMMs polarization toward M1 phenotype.
S1P/S1PR 2/3 -mediated the M1 polarization depends on the G(α) i/o /PI3K/JNK signal pathway
As we found that JNK and PI3K pathways were involved in S1P-induced M1 polarization, we next investigated whether these pathways are influenced by S1P/S1PR 2/3 . Western blotting assay revealed that S1P alone induced a significant increase in the protein level of phospho-JNK1/2 (~3.5 fold) and kept longer excitation of JNK1/2 (Fig. 6A) . To further confirm it, immunofluorescence assays were used to identify the phosphorylation of JNK1/2 in BMMs. As expected, the immunostaining for phospho-JNK1/2 was clearly detected (Fig. 6B) . Pretreatment with PTX, S1PR antagonists JTE-013 or CAY-10444 prevented the increase of phospho-JNK1/2, respectively (Fig. 6A) . Moreover, we found that PI3K inhibitor LY294002 can prevent S1P-induced phospho-JNK1/2 (Fig. 6A) , implying JNK as an obligatory downstream target of PI3K pathway in S1P-reduced BMMs polarized toward M1 phenotype. Altogether, these results show that G(a) i/o protein coupled with S1PR 2/3 mediates S1P-induced M1 macrophage polarization through PI3K/JNK signal pathway.
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Discussion
In the present study, we reveal that S1PR 2/3 , but not S1PR 1 , mediates S1P-induced M1 macrophage polarization in BMMs. We also provide evidence that S1PR 2/3 plays a crucial role in the expression of M1 markers in vitro. Inhibition of S1PR 2/3 decreases BMM polarization toward M1 phenotype through G(a) i/o /PI3K/JNK signaling pathway (Fig. 6C) .
BMMs are commonly used and well defined source of macrophages in experimental study [3] . Our previous studies have shown that recruitment of BMMs in the injured liver could aggravate liver inflammation and thus played a crucial role in BDL-or CCl 4 -induced liver disease [20, 29, 30] . Among a variety of factors that mediate switch BMMs to pro-inflammatory M1 phenotype, S1P is probably one of the most potent regulatory molecules [36] . S1P has been implicated in many key cellular processes, including cell proliferation, differentiation, migration and survival [37] . Besides, S1P acts as a crucial inflammatory mediator and can be released in response to inflammation and following injury [36, 38] . Recent studies showed that S1P levels was markedly increased in acutely inflamed tissues and released by apoptotic cells [39] . Moreover, S1P level in serum was regarded as a prognostic factor [40] . Thus, S1P is a promising candidate as a regulator of the different variety of inflammatory disease. S1P has been implicated in the regulation of macrophage functions, including migration and polarization. However, although BMMs are known to have unique characteristics, the roles of S1P signaling in the regulation of macrophage polarization during liver injured are poorly understood. Our preceding study has showed that blockade of S1PR 2/3 decreased liver inflammation and fibrosis by preventing BMM migration [20] . In the current study, we thus investigated the effects of S1P on BMM further, focusing on BMM polarization. Our in vitro studies demonstrated that S1P promoted inflammatory M1 polarization via S1PR 2/3 /G(α) i/o / PI3K/JNK pathway in BMMs. Furthermore, we revealed that CCl 4 administration apparently increased M1 markers expression, and these increases were inhibited by SphK inhibitor, SKI [2-(p-hydroxyanilino)-4-(p-chlorphenyl) thiazole], in mouse injured liver (Fig. 4D) . These findings further support previous studies demonstrating a crucial role of BMMs in liver inflammation [41] . Emerging data suggest that recruitment of BM-derived cells following liver injury promotes liver inflammation [20, 42] . Therefore, further studies will be needed to better explore which BM-derived cells infiltrates the inflamed liver during pathology.
Biological functions of S1P are mainly mediated by its cell surface receptors [19] . For example, recent studies showed that S1PR 2 inhibited chemoattractant-induced motility in murine primary macrophages in vitro and may limit macrophage infiltration into the inflamed peritoneum [13] . In addition, a recent report showed that S1PR 2 induced the cAMP/protein kinase pathway to inhibit macrophage motility in vitro [43] . An earlier study has found that S1PR 2 was needed for TLR4-induced the release of pro-inflammatory cytokines such as IL-1β and IL-18 [44] . Furthermore, during thioglycollate-induced sterile peritonitis, the elevated S1P production in the inflamed peritoneum induces an inflammatory response in the injured site, which in turn stimulates the recruitment of various types of inflammatory cells by promoting S1PR 3 expression [45] . Blockade of S1PR 3 by antagonist or knockout limits the accumulation of peritoneal macrophage cells in the inflamed site in vivo [45] . Our previous studies have shown that the BMMs played a crucial role in BDL-or CCl 4 -induced liver disease [20, 29] . Inhibition of S1PR 2/3 depressed M1 mobility and thus attenuated the inflammation and liver fibrosis in injured liver [20] . These above results have showed significant contributions of S1PRs on macrophages, but which S1P receptor subtype mediated M1 polarization remains unclear. A key finding of the present study is that S1PR 2/3 is involved in M1 polarization in BMMs. These data are in agreement with recent studies highlighting a central role of S1P-induced immune cell polarization in many different cellular types including T cell, macrophage, and mast cell [46] , further proving that S1P production is necessary for M1 polarization. Many studies have reported that polarization of immune cells appear to be mediated via the binding of S1P to S1P receptors [37] . However, S1P signaling is complex and may have both pro-and anti-inflammatory properties, especially for BMMs. In an earlier study, Park et al. showed that S1P stimulated M2 phenotype polarization of macrophages via IL-4 [10] . The reason might be that distinct macrophages were used, BMMs were obtained from ICR mice in the present experiments, while peritoneal macrophages from C57BL/6 mice in the study conducted by Park et al. Furthermore, owing to their different origins, BMMs and peritoneal macrophages may have distinct gene expression profile which causes a different response to S1P. The reagents of inducing macrophage polarization were also different, S1P was used alone in the current experiments, but S1P was used in conjunction with LPS in the study conducted by Park et al.. Furthermore, S1P induced macrophage toward anti-inflammatory phenotype in tumor environment [46] . We reason that the roles of S1P on functional phenotype of macrophage might be diverse depending on the expression of different S1P receptors in different tissue, as well as on their different inflammatory microenvironment.
As the complexity of M1 polarization, it is crucial to understand the molecular signaling cascades in the regulation process of BMM polarization by S1P. S1PRs are seventransmembrane G-protein-coupled receptors, which are linked predominantly to G(a) i/o protein and thus generate a various biological action [47] . A review showed activations of S1PRs induced complex signal transduction such as PI3K and mitogen activated protein kinase (MAPK) [47, 48] . Here we show that inhibition of G(a) i/o protein signal by PTX reduces S1P/S1PR 2/3 -mediated M1 polarization of BMMs. The result demonstrated that the signal of S1P/S1PR 2/3 coupling G(a) i/o protein triggered the release of macrophages pro-inflammatory cytokines, and promoted BMMs polarized toward M1 phenotype. Studies have shown that JNK1/2 was important for pro-inflammatory macrophage polarization [22, 25] and PI3K has been shown to be related to polarization of various cell types [49] . Here we revealed that S1P/S1PR 2/3 -induced increase of M1 markers is abrogated by specific G(a) i/o , PI3K or JNK inhibitors, indicating that PI3K/JNK signaling pathway might be involved in M1 phenotype polarization of macrophage. Inhibition of S1PR 2/3 , G(a) i/o or PI3K can prevent the phospho-JNK induced by S1P. The result above suggested that JNK may function as an downstream activator of G(a) i/o and PI3K. Our previous study also has reported that S1P activated PI3K and Rac1 to promote macrophage migration [20] . In this study the expression of S1PRs in BMM was already shown and a down-regulation of pro-inflammatory cytokines including MCP-1, IL-12 and IL-6 was shown to occur by the use of S1PR antagonists in the context of liver injury that could be related to a reduced infiltration of macrophages into the injured liver [20] . To further determine whether M1 polarization in BMMs associated with higher mobility, we performed the experiments to determine the effect of S1P on the mobility of M1, M2 macrophages. The analysis on cell migration demonstrated that S1P did not affect the mobility of macrophages in different polarization states (Fig. 4C) , indicating that the increase in S1P-induced M1 phenotype was due to macrophage polarization. Further studies will be needed to illustrate the exact molecular mechanisms by which S1P/S1PR 2/3 mediates M1 polarization in BMMs. Moreover, although we have carefully verified that S1P/S1PR 2/3 mediated M1 polarization in BMMs, in the present study, however, mainly employed an in vitro model that might not completely reflect a real impact on macrophage biology, the effect of S1PR 2/3 on M1 polarization of BMMs in the progression of liver inflammation remains unclear. The future experiments may need to be designed to better explore whether S1PR 2/3 inhibition is associated to reduction of M1 genes in injured liver.
Conclusion
In summary, the results of this study provide the genetic and pharmacologic evidence to support the hypothesis that S1PR 2 and S1PR 3 pathway play a crucial role in BMM polarized toward M1 phenotype in a positive manner. This work identifies new clues to the molecular mechanisms underlying the production of M1 genes elicited by G(a) i/o coupled with S1PR 2/3 and PI3K/JNK signal pathway. These results expand our understanding of S1PR 2/3 and the regulation of M1 genes expression. Recently, M1 macrophages have been regarded as a therapeutic target for inflammatory disease treatment. Our results reveal the possibility
